Emergency supply at patient request — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Confirm the prescribed weekly dosing day before supply and reinforce it with the patient
Explanation lettering: E = shown as A · D = shown as B · B = shown as C · A = shown as D · C = shown as E
A is wrong because the unresolved day creates a real risk of duplicate or incorrect dosing. B is wrong because “take as directed” abandons a key methotrexate safety safeguard. C is wrong because reducing quantity does not resolve the schedule. D is wrong because a strength change requires prescriber authority and may introduce further error. E is correct: weekly methotrexate requires an unambiguous agreed day, clear directions and counselling to prevent fatal daily or duplicate dosing.
Reference: MHRA: once-weekly methotrexate safety measures. https://www.gov.uk/drug-safety-update/methotrexate-once-weekly-for-autoimmune-diseases-new-measures-to-reduce-risk-of-fatal-overdose-due-to-inadvertent-daily-instead-of-weekly-dosing GPhC: standards for pharmacy professionals. https://assets.pharmacyregulation.org/files/standards_for_pharmacy_professionals_may_2017_0.pdf